Genetic selection of phage engineered for receptor-mediated gene transfer to mammalian cells
- PMID: 10544031
- DOI: 10.1006/bbrc.1999.1603
Genetic selection of phage engineered for receptor-mediated gene transfer to mammalian cells
Abstract
Although phage display is a powerful way of selecting ligands against purified target proteins, it is less effective for selecting functional ligands for complex targets like living cells. Accordingly, phage display has had limited utility in the development of targeting agents for gene therapy vectors. By adapting a filamentous bacteriophage for gene delivery to mammalian cells, however, we show here that it is possible to screen phage libraries for functional ligands capable of delivering DNA to cells. For example, when targeted with epidermal growth factor (EGF), M13 bacteriophage were capable of delivering a green fluorescent protein (GFP) gene to EGF receptor bearing cells in a ligand-, time-, and phage concentration-dependent manner. The EGF-targeted phage transduced COS-1 cells in a highly specific manner as demonstrated by competition with excess free EGF or alternatively with anti-EGF receptor antibodies. We further demonstrate that EGF-phage can be selected, by their ability to transduce EGF receptor bearing cells from libraries of peptide display phage. When phage were incubated with COS-1 cells, EGF ligand-encoding sequences were recovered by PCR from FACsorted, GFP-positive cells and the EGF-displaying phage were enriched 1 million-fold by four rounds of selection. These data suggest the feasibility of applying molecular evolution to phage gene delivery to select novel cell-specific DNA-targeting ligands. The same approach could be used to select genetically altered phage that are specifically designed and evolved as gene therapy vectors.
Copyright 1999 Academic Press.
Similar articles
-
Targeted gene delivery to mammalian cells by filamentous bacteriophage.J Mol Biol. 1999 Apr 30;288(2):203-11. doi: 10.1006/jmbi.1999.2678. J Mol Biol. 1999. PMID: 10329137
-
Receptor-targeted gene delivery using multivalent phagemid particles.Mol Ther. 2001 Apr;3(4):476-84. doi: 10.1006/mthe.2001.0284. Mol Ther. 2001. PMID: 11319907
-
Phage as gene delivery vectors.Curr Opin Mol Ther. 2001 Apr;3(2):159-69. Curr Opin Mol Ther. 2001. PMID: 11338929 Review.
-
Targeted gene transduction of mammalian cells expressing the HER2/neu receptor by filamentous phage.J Mol Biol. 2001 Nov 9;313(5):965-76. doi: 10.1006/jmbi.2001.5111. J Mol Biol. 2001. PMID: 11700053
-
Targeting of phage display vectors to mammalian cells.Comb Chem High Throughput Screen. 2000 Oct;3(5):373-92. doi: 10.2174/1386207003331517. Comb Chem High Throughput Screen. 2000. PMID: 11032955 Review.
Cited by
-
Engineered Bacteriophage T7 as a Potent Anticancer Agent in vivo.Front Microbiol. 2020 Sep 24;11:491001. doi: 10.3389/fmicb.2020.491001. eCollection 2020. Front Microbiol. 2020. PMID: 33072000 Free PMC article.
-
Making the leap from technique to treatment - genetic engineering is paving the way for more efficient phage therapy.Biochem Soc Trans. 2024 Jun 26;52(3):1373-1384. doi: 10.1042/BST20231289. Biochem Soc Trans. 2024. PMID: 38716972 Free PMC article. Review.
-
Targeting the choroid plexus-CSF-brain nexus using peptides identified by phage display.Methods Mol Biol. 2011;686:483-98. doi: 10.1007/978-1-60761-938-3_25. Methods Mol Biol. 2011. PMID: 21082389 Free PMC article.
-
Screening and identification of a novel hepatocellular carcinoma cell binding peptide by using a phage display library.J Huazhong Univ Sci Technolog Med Sci. 2008 Jun;28(3):299-303. doi: 10.1007/s11596-008-0316-1. Epub 2008 Jun 19. J Huazhong Univ Sci Technolog Med Sci. 2008. PMID: 18563328
-
A phage-targeting strategy for the design of spatiotemporal drug delivery from grafted matrices.Fibrogenesis Tissue Repair. 2011 Feb 17;4:7. doi: 10.1186/1755-1536-4-7. Fibrogenesis Tissue Repair. 2011. PMID: 21329515 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical